EPCAM and liver cancer: It is not unique that after chemotherapy, the expression of stem-related molecules such as EpCAM, CD326, CD24, and NANOG increased in hematological tumors, liver cancer cells [21], pancreatic cancer cells, colon cancer cells, and peritoneal metastasis cells [46] (Figure 1).